| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| General health | 5 | 1 | |
| Amyotrophic lateral sclerosis | 1 | 0 | |
| Hair loss | 1 | 0 | |
| Human immunodeficiency virus (HIV) | 1 | 1 | |
| Toxoplasmosis | 1 | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 0 | |
| None | 1 |